STAT+: Pharmalittle: We’re reading about Dems eyeing Trump MFN deals, fewer drug launches in Europe, and more
Incoming Democratic chairs of key congressional committees have taken a new step toward investigating most-favored nation drug pricing agreements
We haven't written up this one. STAT News has the full story — the link below goes straight to it.